- An interesting molecule - valsartan2007 | Publication without faculty affiliation
- Sacubitril/valsartan in the treatment of chronic heart failure2016 | First Faculty of Medicine
- What does the fixed combination of valsartan and sacubitrilu patients with heart failure - the results of the study PARADIGM-HF2017 | Faculty of Medicine in Hradec Králové
- Quality of life and sacubitril/valsartan2019 | First Faculty of Medicine
- Sacubitril-valsartan in the treatment of chronic heart failure with decreased left ventricular ejection fraction2017 | First Faculty of Medicine
- Monitoring the dynamics of clinical and laboratory markers of chronic heart failure during 12 months of sacubitril/valsartan treatment2021 | First Faculty of Medicine
- Sacubitril/valsartan in the treatment of heart failure with severe left ventricular systolic dysfunction2021 | First Faculty of Medicine
- Valsartan v monoterapii i kombinační léčbě kardiovaskulárních onemocnění2022 | First Faculty of Medicine
- Sakubitril/valsartan u diabetiků se srdečním selháním s nízkou ejekční frakcí2019 | First Faculty of Medicine
- Fixed combination of perindopril / amlodipine and valsartan / amlodipine when initiating treatment for hypertension results of an international multicenter study2016 | First Faculty of Medicine
- Sakubitril/valsartan v léčbě EFLK z pohledu nefrologa2017 | First Faculty of Medicine
- PARAGON-HF study (Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction)2020 | First Faculty of Medicine
- Sacubitril/valsartan - new dual inhibitor of neprilysin and angiotensin II receptors2016 | First Faculty of Medicine
- Pharmacotherapy of chronic heart failure in senescence2023 | Faculty of Medicine in Hradec Králové
- The efficacy and safety of valsartan and combination of valsartan and hydrochlorothiazide in the treatment of patients with mild to moderate arterial hypertension - the VICTORY trial2017 | First Faculty of Medicine
- Přínos zahájení léčby sacubitril-valsartanem u pacientů s akutní dekompenzací srdečního selhání se sníženou ejekční frakcí2020 | First Faculty of Medicine
- The efficacy and safety of valsartan and a combination of valsartan and hydrochlorothiazide in the treatment of patients with mild to moderate arterial hypertension: a subgroup analysis of the effect of valsartan and its combination with hydrochlorothiazide on pulse wave velocity and central blood pressure2018 | First Faculty of Medicine
- Sakubitril/valsartan v léčbě srdečního selhání na podkladě trikuspidální regurgitace a dysfunkce pravé komory2023 | First Faculty of Medicine
- VATARO - the story continues. Ordering a pilot study results2015 | First Faculty of Medicine
- A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction2020 | First Faculty of Medicine
- Improved clinical status persisting for several months while on sacubitrilvalsartan in a patient with systolic dysfunction of rather unclear etiology2017 | First Faculty of Medicine
- A new, rapid, stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan and hydrochlorothiazide in their combined tablet dosage form2015 | Faculty of Science
- Rationale and design of TRANSITION: a randomized trial of pre-discharge vs. post-discharge initiation of sacubitril/valsartan2018 | First Faculty of Medicine
- Pharmacological therapy for chronic heart failure2018 | First Faculty of Medicine
- Initiation of sacubitril/valsartan shortly after hospitalisation for acutely decompensated heart failure in patients with newly diagnosed (de novo) heart failure: a subgroup analysis of the TRANSITION study2020 | First Faculty of Medicine
- Sacubitril/Valsartan and Ivabradine Attenuate Left Ventricular Remodelling and Dysfunction in Spontanenously Hypertensive Rats: Different Interaction with the Renin-Angiotensin-Aldosterone System2022 | Faculty of Medicine in Hradec Králové
- Studie VICTORY: Stručná prezentace hlavních výsledků2016 | First Faculty of Medicine
- Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study2019 | First Faculty of Medicine
- New concept in the treatment of cardiovascular diseases - dual inhibition of neutral endopeptidase and RAA system2017 | First Faculty of Medicine
- Influence of diabetes on sacubitril/valsartan titration and clinical outcomes in patients hospitalized for heart failure2023 | First Faculty of Medicine